The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders
Crossref DOI link: https://doi.org/10.1038/leu.2017.139
Published Online: 2017-05-09
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Maslah, N
Cassinat, B
Verger, E
Kiladjian, J-J
Velazquez, L
Text and Data Mining valid from 2017-05-09
Version of Record valid from 2017-05-09
Article History
Received: 2 March 2017
Revised: 10 April 2017
Accepted: 24 April 2017
First Online: 9 May 2017
Competing interests
: The authors declare no conflict of interest.